Literature DB >> 8133556

Respiratory syncytial virus infection in young children hospitalized with respiratory illness in Riyadh.

G A Jamjoom1, A M al-Semrani, A Board, A R al-Frayh, F Artz, K F al-Mobaireek.   

Abstract

The occurrence of respiratory syncytial virus (RSV) infection among young children hospitalized with lower respiratory tract illness, at King Khalid University Hospital in Riyadh, was examined during the autumn-winter season between September 1991 and February 1992. Sixty-nine cases were diagnosed by immunofluorescent antibody staining of viral antigen in nasopharyngeal aspirates from 127 children, constituting 54 per cent of these patients. Virus culture was attempted only in a few cases, yielding two isolates. Most children were < 1 year of age (median 2 months). Bronchiolitis and bronchopneumonia were the major diagnoses on admission. Hospitalization was for an average of 5 days (range 1-36 days). Treatment was supportive but most children received antibiotic therapy. There was no mortality. Few other bacterial or viral pathogens could be identified from RSV-positive or -negative patients. These results indicate that, during the season of infection, RSV may be the main pathogen of lower respiratory tract illness in hospitalized young children in this region.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133556     DOI: 10.1093/tropej/39.6.346

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  5 in total

1.  The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus.

Authors:  S Yusuf; G Piedimonte; A Auais; G Demmler; S Krishnan; P Van Caeseele; R Singleton; S Broor; S Parveen; L Avendano; J Parra; S Chavez-Bueno; T Murguía De Sierra; E A F Simoes; S Shaha; R Welliver
Journal:  Epidemiol Infect       Date:  2007-03-08       Impact factor: 2.451

2.  Human rhinovirus C: Age, season, and lower respiratory illness over the past 3 decades.

Authors:  Jodell E Linder; David C Kraft; Yassir Mohamed; Zengqi Lu; Luke Heil; Sharon Tollefson; Benjamin R Saville; Peter F Wright; John V Williams; E Kathryn Miller
Journal:  J Allergy Clin Immunol       Date:  2012-11-10       Impact factor: 10.793

3.  Co-Circulation of 72bp Duplication Group A and 60bp Duplication Group B Respiratory Syncytial Virus (RSV) Strains in Riyadh, Saudi Arabia during 2014.

Authors:  Anwar Ahmed; Shakir H Haider; Shama Parveen; Mohammed Arshad; Hytham A Alsenaidy; Alawi Omar Baaboud; Khalid Fahad Mobaireek; Muslim Mohammed AlSaadi; Abdulrahman M Alsenaidy; Wayne Sullender
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

4.  Saudi experts' recommendation for RSV prophylaxis in the era of COVID-19: Consensus from the Saudi Pediatric Pulmonology Association.

Authors:  Adel S Alharbi; Mohamed Alzahrani; Abdulrahman N Alodayani; Mohamed Y Alhindi; Saleh Alharbi; Abdulrahman Alnemri
Journal:  Saudi Med J       Date:  2021-04       Impact factor: 1.484

5.  Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children.

Authors:  Saleh Al-Alaiyan; Paul Pollack; Gerard F Notario
Journal:  Drugs Context       Date:  2015-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.